Heather Bresch Press Release

Title Picture
05/14/2018 - 12:55
Mylan and West Virginia University Join Forces to Inspire West Virginia Youth Through STEM-CARE
Mylan's picture
Mylan
04/11/2018 - 11:19
Mylan to Leverage its World-Class Scientific Platform to Develop a Novel Delivery for Meloxicam, a Non-Opioid Pain Medication
Mylan's picture
Mylan
04/11/2018 - 09:28
Investor Day Highlights Durability of Mylan's Global Platform
Mylan's picture
Mylan
04/11/2018 - 07:00
Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira (adalimumab)
Mylan's picture
Mylan
03/28/2018 - 06:14
Mylan Introduces Symfi Triple Combo Once-Daily HIV Treatment in the U.S.
Mylan's picture
Mylan
03/21/2018 - 05:55
Mylan to Host Investor Day on April 11, 2018, in New York City
Mylan's picture
Mylan
03/02/2018 - 10:04
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan's picture
Mylan
02/26/2018 - 06:58
Mylan Defeats Allergan's Maneuver to Rent Tribal Sovereign Immunity to Avoid Restasis Patent Challenge
Mylan's picture
Mylan
02/20/2018 - 09:48
Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program
Mylan's picture
Mylan
02/01/2018 - 07:04
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva Tablets
Mylan's picture
Mylan
12/29/2017 - 11:26
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace Cream
Mylan's picture
Mylan
12/29/2017 - 00:10
Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs
Mylan's picture
Mylan
12/14/2017 - 06:50
Mylan Announces the U.S. Patent and Trademark Appeal Board Institutes Inter Partes Review Proceedings on All Claims Against Sanofi's Lantus Patents
Mylan's picture
Mylan
12/01/2017 - 08:54
U.S. FDA Approves Mylan and Biocon's Ogivri, the First Biosimilar for Trastuzumab, for the Treatment of HER2-Positive Breast and Gastric Cancers
Mylan's picture
Mylan
10/05/2017 - 12:39
Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone 40 mg/mL
Mylan's picture
Mylan
10/04/2017 - 04:16
Mylan Provides Support for U.S. Disaster-Relief Efforts
Mylan's picture
Mylan
10/03/2017 - 16:44
Mylan Announces U.S. FDA Approval of First Generic for Copaxone 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity
Mylan's picture
Mylan
09/13/2017 - 05:45
Mylan Names Dennis Zeleny as Chief Human Relations Officer
Mylan's picture
Mylan
08/17/2017 - 08:36
Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen Auto-Injector
Mylan's picture
Mylan
05/16/2017 - 09:45
Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health
Mylan's picture
Mylan
03/29/2017 - 14:41
Mylan Completes Acquisition of Cold-EEZE Brand
Mylan's picture
Mylan
03/28/2017 - 07:49
Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
Mylan's picture
Mylan
03/13/2017 - 05:13
Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin
Mylan's picture
Mylan
03/03/2017 - 06:55
CNBC Exclusive: CNBC Transcript: Mylan CEO Heather Bresch Speaks with CNBCs Power Lunch Today
CNBC's picture
CNBC
02/14/2017 - 13:09
Mylan Applauds the Generic Pharmaceutical Association's Rebrand to the Association for Accessible Medicines
Mylan's picture
Mylan
02/03/2017 - 05:19
Mylan to Host Investor Day on March 1, 2017 in New York City
Mylan's picture
Mylan
01/30/2017 - 22:36
Mylan Wins U.S. District Court Ruling Related to Copaxone 40 mg/mL Patents
Mylan's picture
Mylan
12/29/2016 - 15:55
Mylan Launches Generic Concerta Tablets
Mylan's picture
Mylan
12/16/2016 - 07:11
Mylan Launches the First Generic for EpiPen (epinephrine injection, USP) Auto-Injector as an Authorized Generic
Mylan's picture
Mylan
12/01/2016 - 06:54
Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever
Mylan's picture
Mylan
10/10/2016 - 16:51
New RN Report: Pharma CEOs Reaped $2.8 Billion Last Year While Implementing Massive Price Hikes
National Nurses United's picture
National Nurses...
10/07/2016 - 14:43
Mylan Agrees to Settlement on Medicaid Rebate Classification for EpiPen Auto-Injector
Mylan's picture
Mylan
09/21/2016 - 01:53
Hastings Bioethics Forum Blog
Hastings Center's picture
Hastings Center
09/09/2016 - 04:55
EpiPens and Government Cheese
Reason Foundation's picture
Reason Foundation
09/01/2016 - 15:35
Mylan Invalidates Third Teva Copaxone 40 mg/mL Patent Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding
Mylan's picture
Mylan
08/29/2016 - 14:40
Lobbyists For EpiPen Maker Included Former Clinton and McConnell Aides
Reason Foundation's picture
Reason Foundation
08/29/2016 - 03:19
Mylan to Launch First Generic to EpiPen Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product
Mylan's picture
Mylan
08/25/2016 - 03:51
Mylan Taking Immediate Action to Further Enhance Access to EpiPen (Epinephrine Injection, USP) Auto-Injector
Mylan's picture
Mylan
08/24/2016 - 15:16
Mylan Invalidates Two of Teva's Copaxone 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding
Mylan's picture
Mylan
08/17/2016 - 14:58
Homes for West Virginia Partners with Appalachia Service Project on Rebuilding Rainelle to Help Town Devastated by June Flooding
Mylan's picture
Mylan
08/05/2016 - 09:37
Mylan Completes Acquisition of Meda
Mylan's picture
Mylan
06/23/2016 - 22:15
Mylan Donates 1 Million to the Princess Maxima Center for Pediatric Oncology
Mylan's picture
Mylan
06/15/2016 - 20:01
Mylan Completes Acquisition of Renaissance's Leading Topicals-Focused Specialty and Generics Business
Mylan's picture
Mylan
06/01/2016 - 20:20
Mylan Launches First Generic of Nuvigil Tablets
Mylan's picture
Mylan
05/13/2016 - 13:45
Mylan to Acquire Renaissance's Leading Topicals-Focused Specialty and Generics Business
Mylan's picture
Mylan
01/08/2016 - 16:01
Momenta Pharmaceuticals Announces Worldwide Collaboration With Mylan to Jointly Develop and Commercialize Six Biosimilar Products
Momenta's picture
Momenta